SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-313772
Filing Date
2013-08-01
Accepted
2013-08-01 06:07:11
Documents
3
Period of Report
2013-07-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d577580d8k.htm 8-K 15300
2 EX-3.1 d577580dex31.htm EX-3.1 4737
3 EX-99.1 d577580dex991.htm EX-99.1 8988
  Complete submission text file 0001193125-13-313772.txt   30354
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52228 | Film No.: 131000764
SIC: 8731 Services-Commercial Physical & Biological Research